Week of 2026-11-09
Nineteen trades were disclosed this week, with technology stocks dominating both the buy and sell sides and four potential conflicts flagged for Senate members whose committee work touches the sector.
The Big Picture
Members of Congress disclosed 19 trades covering the period around late October. Technology was the most active sector, appearing in both the most-bought and most-sold categories — an unusual split that suggests members were rotating within the space rather than making a broad directional call. Republicans accounted for 14 of the 19 disclosures; Democrats filed five. The week's largest single position was a corporate bond sale by Rep. Ann Wagner of Missouri, valued between $100,001 and $250,000.
This Week's Notable Trades
Ann Wagner (R-MO)
- Sold a $100,001–$250,000 position in a corporate bond issued by American Express National Bank on October 20. A corporate bond is a fixed-income debt security — essentially a loan to a company that pays regular interest. This was the largest disclosed position by dollar range this week.
Shelley Moore Capito (R-WV)
- Sold a $1,001–$15,000 position in Apple Inc (AAPL) on October 21. Apple is the maker of the iPhone, Mac computers, and the App Store.
- Sold a $1,001–$15,000 position in Meta Platforms Inc (META) on October 21. Meta owns Facebook, Instagram, and WhatsApp.
- Sold a $1,001–$15,000 position in Microsoft Corp (MSFT) on October 21. Microsoft makes the Windows operating system, Office software, and the Azure cloud computing platform.
- Sold a $1,001–$15,000 position in Zoetis Inc (ZTS) on October 21. Zoetis is the world's largest animal health company, producing medicines and vaccines for livestock and pets.
- Potential conflict: Sen. Capito sits on the Senate Commerce, Science, and Transportation Committee, which has broad oversight of technology companies and internet platforms. Three of her four disclosed sales — Apple, Meta, and Microsoft — are companies that fall within that committee's jurisdiction.
Sheldon Whitehouse (D-RI)
- Sold a $15,001–$50,000 position in Amgen Inc (AMGN) on October 15. Amgen is one of the world's largest biotechnology companies, known for treatments for cancer, cardiovascular disease, and inflammatory conditions. A substantial portion of its revenue flows through Medicare reimbursements.
- Sold a $1,001–$15,000 position in Microsoft Corp (MSFT) on October 15.
- Potential conflict: Sen. Whitehouse serves on the Senate Finance Committee, which has jurisdiction over Medicare, Medicaid, and federal healthcare financing programs. Amgen's business depends significantly on federal reimbursement policy, creating a potential overlap with his committee role.
Maria Elvira Salazar (R-FL)
- Bought a $1,001–$15,000 position in NVIDIA Corporation (NVDA) on October 23. Nvidia makes the graphics processing chips (GPUs) that have become central to artificial intelligence development.
- Bought a $1,001–$15,000 position in The Procter & Gamble Co (PG) on October 23. Procter & Gamble makes widely used consumer brands including Tide, Gillette, and Pampers — often considered a defensive, stable investment.
- Sold a $1,001–$15,000 position in Cisco Systems Inc (CSCO) on October 23. Cisco makes networking hardware and software used by businesses and governments worldwide.
Josh Gottheimer (D-NJ)
- Bought a $1,001–$15,000 position in Applied Materials, Inc. (AMAT) on October 26. Applied Materials manufactures the specialized equipment used to produce semiconductors — the chips at the heart of computers, smartphones, and AI systems.
- Bought a $1,001–$15,000 position in Benchmark Electronics, Inc. (BHE) on October 12. Benchmark Electronics provides contract manufacturing services to technology and defense companies.
- Sold a $1,001–$15,000 position in PT Telekomunikasi Indonesia, Tbk (TLK) on October 15. This is Indonesia's state-owned telecommunications company, traded on the New York Stock Exchange as an American Depositary Receipt — a certificate representing ownership in a foreign company's shares.
Mike Kelly (R-PA)
- Sold a $50,001–$100,000 position in Fairfax County, Virginia general obligation bonds on October 15. General obligation bonds are debt securities issued by local governments and backed by their taxing power — generally considered among the lower-risk fixed-income investments.
- Bought a $50,001–$100,000 position in North Carolina Housing Finance Agency bonds on October 1. Housing finance agency bonds are issued by state agencies to fund affordable mortgage lending programs.
By the Numbers
- Total trades disclosed: 19
- Party split: 14 Republican, 5 Democrat
- Most-bought sector: Technology (4 purchases)
- Most-sold sector: Technology (5 sales)
- Most active member: Rep. Maria Elvira Salazar (R-FL), with 5 disclosures
- Potential conflicts flagged: 4
Notable potential conflicts this week:
- Sen. Shelley Moore Capito (R-WV) — sold Apple (AAPL), Meta (META), and Microsoft (MSFT) while serving on the Senate Commerce, Science, and Transportation Committee, which oversees technology and internet platforms.
- Sen. Sheldon Whitehouse (D-RI) — sold Amgen (AMGN) while serving on the Senate Finance Committee, which oversees Medicare, Medicaid, and federal healthcare spending.
Late to File
No late filings were among this week's disclosures. Every trade reported this week was filed within the STOCK Act's 45-day window.
Looking at the broader historical record, about 12.4 percent of all congressional trade disclosures on file — 2,900 of 23,298 total filings — have been submitted late at some point. The members with the most all-time late filings are Rep. Sheri Biggs (171), Rep. Julia Letlow (136), Rep. Valerie Hoyle (114), Sen. Thomas H. Tuberville (108), and Rep. Alan Armstrong (96). Late disclosure is a timing compliance matter, not an indication of improper trading activity.
The Fine Print
Data derived from public STOCK Act disclosures. Disclosure date is not the trade date (filings lag 30-45 days). Dollar figures are disclosed ranges, not exact amounts. Conflict-of-interest flags are heuristic "potential overlaps," not assertions of wrongdoing. Not investment advice.